EUCTR2009-010758-36-NL进行中（未招募）不适用
Pyridostigmine: using a cholinesterase inhibitor to activate the cholinergic anti-inflammatory pathway in patients with CRPS-1 - Pyridostigmine trial
VU University Medical Center0 个研究点目标入组 10 人开始时间: 2009年3月2日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •CRPS-1 patients (Veldman criteria).
- •Age > 18 jaar
- •Standard treatment does not solve the complaints adequately.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •kydney failure
- •other chronic pain syndromes
- •parkinson's disease
- •operations on the digestive tract in medical history
- •active malignancy
- •mental retardation
研究者
相似试验
已完成
2 期
Pyridostigmine: using a cholinesterase inhibitor to activate the cholinergic anti-inflammatory pathway in patients with CRPS-1pijn syndroomdystrophypost-traumatic dystrophyreflex sympathetic dystrophyNL-OMON33787Vrije Universiteit Medisch Centrum10
尚未招募
不适用
The effect of Pyridostigmine on patients with CRPS-1.complex regional pain syndrome, neuropathic pain, neurogenic inflammation,NL-OMON20521TREND10
进行中（未招募）
3 期
The use of Pyridostigmine bromide in the treatment of fatigue secondary to COVID-19Post-Viral Fatigue SyndromeCOVID-19C01.925RBR-107j3g4vniversidade Federal Fluminense
招募中
3 期
Effect of pyridostigmine in stroke-related dysphagiaIRCT20230520058232N1Sanandaj University of Medical Sciences60
已完成
1 期
AchE Inhibitor and InsulinDiabetes MellitusNCT03063515University of Miami12